NEW YORK, Sept. 2 (TNSjou) -- Cornell University - Weill Cornell Graduate School of Medical Sciences posted the following news:

* * *

Antifungal Therapy Shows Potential for IBD Patients with Candida Overgrowth

A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study by Weill Cornell Medicine investigators.